Resistance to drugs in many common childhood infections is a growing problem in the developing world, says Zulfiqar Bhutta (doi: 10.1136/bmj.39520.680718.94). Effective programmes to combat resistance are within reach in developing countries, argue Ralph Gonzales and colleagues, but we must move swiftly